| Literature DB >> 24634843 |
Kalyani D Asgaonkar1, Ganesh D Mote1, Trupti S Chitre1.
Abstract
A quantitative structure-activity relationship model was developed on a series of compounds containing oxadiazole-ligated pyrrole pharmacophore to identify key structural fragments required for anti-tubercular activity. Two-dimensional (2D) and three-dimensional (3D) QSAR studies were performed using multiple linear regression (MLR) analysis and k-nearest neighbour molecular field analysis (kNN-MFA), respectively. The developed QSAR models were found to be statistically significant with respect to training, cross-validation, and external validation. New chemical entities (NCEs) were designed based on the results of the 2D- and 3D-QSAR. NCEs were subjected to Lipinski's screen to ensure the drug-like pharmacokinetic profile of the designed compounds in order to improve their bioavailability. Also, the binding ability of the NCEs with enoyl-ACP (CoA) reductase was assessed by docking.Entities:
Keywords: 2D quantitative structure-activity relationship; 3D quantitative structure-activity relationship; Antitubercular; Docking; Enoyl ACP co Reductase; Mycobacterium tuberculosis; Oxadiazole ligated pyrrole
Year: 2013 PMID: 24634843 PMCID: PMC3951234 DOI: 10.3797/scipharm.1310-05
Source DB: PubMed Journal: Sci Pharm ISSN: 0036-8709
Uni-Column statistics for the training set and test set.
| Model-1 | Column name | Average | Max | Min | Std.dev. | Sum |
|---|---|---|---|---|---|---|
| Training | pMIC | −1.1986 | −0.1761 | −2.1638 | 0.7035 | −19.1770 |
| Test | pMIC | −1.6286 | −0.9542 | −2.0719 | 0.4754 | −6.5146 |
Correlation matrix
| Descriptor | chiV3Cluster | XKAverage | T_O_O_5 | Rotatable Bond Count | SdsCHE-index |
|---|---|---|---|---|---|
| chiV3Cluster | 1 | −0.4728 | −0.61661 | −0.63246 | 0.3423 |
| XKAverage | −0.4728 | 1 | 0.71216 | 0.726289 | 0.444362 |
| T_O_O_5 | −0.61661 | 0.71216 | 1 | 0.729458 | 0.553539 |
| Rotatable Bond Count | −0.63246 | 0.726289 | 0.729458 | 1 | 0.5 |
| SdsCHE-index | 0.3423 | 0.444362 | 0.553539 | 0.5 | 1 |
| pMIC | 0.9387 | 0.6475 | −0.1257 | 0.2749 | 0.4148 |
Statistical results of 2D- QSAR generated by MLR
| Statistical Parameter | 2D- QSAR MLR analysis values | Contributing descriptors |
|---|---|---|
| n | 16 | chiV3Cluster |
| r2 | 0.9827 | XKAverage |
| r2 se | 0.1134 | T_O_O_5 |
| q2 | 0.5754 | RotatableBondCount |
| q2 se | 0.3615 | SdsCHE-index |
| F test | 113.3738 | |
| pred_r2 | 0.8392 | |
| pred_r2se | 0.2757 |
Fig. 1a: Contribution plot of selected descriptors.
b: Plot of Actual versus predicted Activity
Fig. 2Common template data points generated using the kNN–MFA method (3D-QSAR) in a 3D rectangular grid showing contributions of electrostatic, hydrophobic, and steric functional groups for significant antitubercular activity.
Statistical results of 3D- QSAR generated by SA kNN-MFA
| Statistical parameter | 3D-QSAR SA-kNN-MFA |
|---|---|
| q2 | 0.5124 |
| q2 se | 0.3647 |
| Pred_r2 | 0.7166 |
| Pred_r2 se | 0.4207 |
| N | 15 |
| K nearest neighbor | 2 |
| Contributing descriptors | S_1048, H_457, E_348, E_235 |
Fig. 3Pharmacophoric requirements around pyrrole-ligated oxadiazole derivatives
Structures of designed NCEs.
|
| |||
|---|---|---|---|
|
| |||
| Cpd. no. | R | Cpd. no. | R |
| 1 | 3-chlorophenyl | 7 | 3-ethylphenyl |
| 2 | 3-bromophenyl | 8 | 3-methoxyphenyl |
| 3 | 3-iodophenyl | 9 | 4-methoxyphenyl |
| 4 | 4-methylphenyl | 10 | 2-methoxyphenyl |
| 5 | 4-ethylphenyl | 11 | 2-nitrophenyl |
| 6 | 3-methylphenyl | 12 | 3-nitrophenyl |
Results of docking studies of designed compounds of oxadiazole-ligated pyrrole series
| Cpd. No. | G-Score | Hydrogen bonds | Good vdw | Bad vdw | ugly |
|---|---|---|---|---|---|
| −7.099278 | 1 | 224 | 0 | 0 | |
| −6.833546 | 1 | 226 | 0 | 0 | |
| −6.538829 | 1 | 239 | 3 | 0 | |
| −6.440214 | 1 | 220 | 7 | 0 | |
| −6.382636 | 1 | 214 | 2 | 0 | |
| −6.293452 | 1 | 197 | 3 | 0 | |
| −6.146766 | 0 | 235 | 5 | 0 | |
| −6.86602 | 1 | 238 | 9 | 0 | |
| −6.05158 | 1 | 242 | 7 | 0 | |
| −6.96048 | 1 | 246 | 8 | 0 | |
| −7.09647 | 2 | 196 | 3 | 0 | |
| −6.05158 | 1 | 207 | 1 | 1 | |
| −7.500947 | 3 | 155 | 0 | 0 |
Fig. 4Docking interaction of (a) isoniazid with Enoyl-ACP (CoA) reductase and (b) Interaction of compound 11 with Enoyl-ACP (CoA) reductase
Selected series of oxadiazole-ligated pyrrole derivatives
|
| |||
|---|---|---|---|
|
| |||
| Cpd. No. | R | MIC(μg/ml) | pMIC |
| 5a | 2-hydroxyphenyl- | 36.50 | −1.56229 |
| 5b | phenylacetic- | 145.80 | −2.16376 |
| 5c | 4-aminophenyl- | 16.50 | −1.21748 |
| 5d | 4-chlorophenyl- | 9.50 | −0.97772 |
| 5e | 4-methoxyphenyl- | 56.50 | −1.75205 |
| 5f | 2,4-dichlorphenyl- | 1.60 | −0.20412 |
| 5g | 2-phenylethenyl | 78.50 | −1.89487 |
| 5h | 4-hydroxyphenyl- | 25.00 | −1.39794 |
| 5i | 5-flouro-2-chlorphenyl- | 6.50 | −0.81291 |
| 5j | 4-nitrophenyl- | 9.00 | −0.95424 |
| 5k | 4,5-dibromo-1H-pyrrol-2-yl- | 3.50 | −0.54407 |
| 5l | phenyl- | 98.70 | −1.99432 |
| 5m | 2-methoxy-4-vinylphenoyl- | 112.50 | −2.05115 |
| 5n | Pyridine-4-yl | 3.50 | −0.5563 |
| 5o | 4H-chromen-3-yl-vinyl- | 2.00 | −0.30103 |
| 6 | -SH | 54.50 | −1.7364 |
| 7a | methyl-S- | 89.50 | −1.95182 |
| 7b | ethyl-S- | 118.00 | −2.07188 |
| 7c | phenyl-S- | 23.50 | −1.37107 |
| 7d | acetophenone-S- | 1.50 | −0.17609 |
indicates test set; pMIC = −logMIC